Cardiol Therapeutics Inc (CRDL)
1.99
+0.01
(+0.51%)
USD |
NASDAQ |
May 03, 16:00
1.99
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Max Drawdown (5Y): 92.71% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 92.71% |
| March 31, 2024 | 92.71% |
| February 29, 2024 | 92.71% |
| January 31, 2024 | 92.71% |
| December 31, 2023 | 92.71% |
| November 30, 2023 | 92.71% |
| October 31, 2023 | 92.71% |
| September 30, 2023 | 92.71% |
| August 31, 2023 | 92.71% |
| July 31, 2023 | 92.71% |
| June 30, 2023 | 92.71% |
| May 31, 2023 | 92.71% |
| April 30, 2023 | 92.71% |
| March 31, 2023 | 92.37% |
| February 28, 2023 | 92.16% |
| January 31, 2023 | 92.16% |
| December 31, 2022 | 92.16% |
| November 30, 2022 | 92.16% |
| October 31, 2022 | 91.34% |
| September 30, 2022 | 83.52% |
| August 31, 2022 | 83.36% |
| July 31, 2022 | 83.36% |
| June 30, 2022 | 83.36% |
| May 31, 2022 | 83.36% |
| April 30, 2022 | 79.81% |
| Date | Value |
|---|---|
| March 31, 2022 | 79.81% |
| February 28, 2022 | 77.38% |
| January 31, 2022 | 77.38% |
| December 31, 2021 | 77.38% |
| November 30, 2021 | 77.38% |
| October 31, 2021 | 77.38% |
| September 30, 2021 | 77.38% |
| August 31, 2021 | 77.38% |
| July 31, 2021 | 77.38% |
| June 30, 2021 | 77.38% |
| May 31, 2021 | 77.38% |
| April 30, 2021 | 77.38% |
| March 31, 2021 | 77.38% |
| February 28, 2021 | 77.38% |
| January 31, 2021 | 77.38% |
| December 31, 2020 | 77.38% |
| November 30, 2020 | 77.38% |
| October 31, 2020 | 77.38% |
| September 30, 2020 | 77.38% |
| August 31, 2020 | 77.38% |
| July 31, 2020 | 77.38% |
| June 30, 2020 | 77.38% |
| May 31, 2020 | 77.38% |
| April 30, 2020 | 77.38% |
| March 31, 2020 | 77.38% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
52.80%
Minimum
May 2019
92.71%
Maximum
Apr 2023
80.32%
Average
77.38%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Aurinia Pharmaceuticals Inc | 87.58% |
| Acasti Pharma Inc | 98.73% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
| Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -28.08 |
| Beta (5Y) | 1.091 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.39% |
| Historical Sharpe Ratio (5Y) | -0.203 |
| Historical Sortino (5Y) | -0.3861 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.54% |